Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference.
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference - CNBC
